DFX Intelligence

Venture Capital Intelligence

Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Iambic Therapeutics, Inc.

Iambic Therapeutics, Inc.

Stage unknownSan Diego, CAiambic.aiBiotechnology

Facts

Year of incorporation: 2019sec.gov
Revenue range (Form D): Decline to Disclosesec.gov
Rounds on record: 3
Disclosed raised: unknownsum of rounds with a disclosed amount only
Named investors: 2

Financing history

3 rounds

Apr 1, 2026
Form D equity offering · $27.8M (form d sold) · 7 investors
Fact SEC EDGAR Form D data sets (quarterly) · “Iambic Therapeutics, Inc. filed Form D: $27,769,668 sold of $49,999,996, Biotechnology”
Nov 6, 2025
Form D equity offering · $99.3M (form d sold) · 22 investors
Fact SEC EDGAR Form D data sets (quarterly) · “Iambic Therapeutics, Inc. filed Form D: $99,269,270 sold of $124,999,970, Biotechnology”
Apr 15, 2024
Form D equity offering · $26.9M (form d sold) · 7 investors
Fact SEC EDGAR Form D data sets (quarterly) · “Iambic Therapeutics, Inc. filed Form D: $26,874,991 sold of $37,999,999, Biotechnology”

Investors on record

2 edges

Ascenta Capital portfolio listing Fact ascentacap.com
Nexus Ventures Management, LLC board only, Jishnu Bhattacharjee (strongly supported) Inference sec.gov

People

6 officers, 7 directors

Fred Manby Executive Officer/Director sec.gov
Michael Secora Executive Officer sec.gov
Neil Josephson Executive Officer sec.gov
Pete Olson Executive Officer sec.gov
Tabbert Teng Executive Officer sec.gov
Thomas Miller Executive Officer/Director sec.gov
Kurt von Emster Director Fact
William Rastetter Director Fact
Evan Rachlin Director Fact
Jishnu Bhattacharjee Director Inference
Shalini Sharp Director Fact
R. Jacob Vogelstein Director Fact
Mary Tagliaferri Director Fact

Timeline

Apr 8, 2026
Iambic Therapeutics, Inc. filed Form D: $27,769,668 sold of $49,999,996, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Nov 21, 2025
Iambic Therapeutics, Inc. filed Form D: $99,269,270 sold of $124,999,970, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Jun 6, 2024
Iambic Therapeutics, Inc. filed Form D/A: $38,383,040 sold of $49,999,998, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
May 7, 2024
Iambic Therapeutics, Inc. filed Form D/A: $29,858,043 sold of $37,999,999, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Apr 25, 2024
Iambic Therapeutics, Inc. filed Form D: $26,874,991 sold of $37,999,999, Biotechnology
Form D filed Fact SEC EDGAR Form D data sets (quarterly)

Evidence

75 observations

Every observation on this company

Entity type: Corporation Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Entity type: Corporation Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Form D industry group: Biotechnology Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: true Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: true May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amendment: false Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Revenue range (Form D): Decline to Disclose Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: overFiveYears Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: withinFiveYears Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: withinFiveYears May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Incorporated: withinFiveYears Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Jurisdiction: DELAWARE Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $27.8M Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $99.3M Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $38.4M Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $29.9M May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Amount sold (Form D): $26.9M Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $50.0M Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $125M Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $50.0M Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $38.0M May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Offering amount (Form D): $38.0M Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Exemptions: 06b Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2026-04-01 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2025-11-06 Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2024-04-15 Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2024-04-15 May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
First sale: 2024-04-15 Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 7 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 22 Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 11 Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 8 May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Investors (Form D): 7 Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Minimum investment (Form D): 0 Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Securities offered: equity Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121 Apr 8, 2026 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121 Nov 21, 2025 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121 Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121 May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Office address: 5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121 Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Listed on portfolio page: Ascenta Capital Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Listed on portfolio page: Ascenta Capital Sep 14, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Year of incorporation: 2019 Jun 6, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Year of incorporation: 2019 May 7, 2024 Fact SEC EDGAR Form D data sets (quarterly)
Year of incorporation: 2019 Apr 25, 2024 Fact SEC EDGAR Form D data sets (quarterly)